You just read:

Akcea and Ionis Announce Positive Results From Pivotal Study of Volanesorsen in Patients With Familial Chylomicronaemia Syndrome (FCS)

News provided by

Akcea Therapeutics

06 Mar, 2017, 17:26 GMT